(Q40741041)

23 September 2017

Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection (English)

1 reference

23 September 2017

Legler TJ

1

1 reference

23 September 2017

Riggert J

2

1 reference

23 September 2017

Simson G

3

1 reference

23 September 2017

Wolf C

4

1 reference

23 September 2017

Humpe A

5

1 reference

23 September 2017

Munzel U

6

1 reference

23 September 2017

Uy A

7

1 reference

23 September 2017

Köhler M

8

1 reference

23 September 2017

Heermann KH

9

1 reference

23 September 2017

1 October 2000

1 reference

23 September 2017

1 reference

23 September 2017

40

1 reference

23 September 2017

10

1 reference

23 September 2017

1192-1197

1 reference

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

23 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101192.X

Risk of hepatitis C virus (HCV) transmission by anti-HCV-negative blood components in Austria and Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101192.X

Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101192.X

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101192.X

High-throughput extraction, amplification, and detection (HEAD) of HCV-RNA in individual blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101192.X

International collaborative study on the second EUROHEP HCV-RNA reference panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101192.X

Performance of the automated COBAS AMPLICOR system for the detection of hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101192.X

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101192.X

Blood donors who are repeatedly reactive for hepatitis C virus on enzyme immunoassay and positive on recombinant immunoblot assay: evidence of failure to identify some risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101192.X

Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101192.X

Hepatitis C virus particle detected by immunoelectron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101192.X

10.1046/J.1537-2995.2000.40101192.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference